Tocilizumab in a Case of Refractory Idiopathic Orbital Inflammation: 6-Year Follow-Up Outcomes

Idiopathic orbital inflammation (IOI) is a noninfectious inflammatory disease whose etiology remains unknown. Treatment is focused on reducing inflammation, which becomes challenging in nonresponding cases. We report the case of a 59-year-old woman with refractory IOI that showed a positive response...

Descripción completa

Detalles Bibliográficos
Autores principales: Artaechevarria Artieda, June, Tapias Elias, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383201/
https://www.ncbi.nlm.nih.gov/pubmed/32774296
http://dx.doi.org/10.1159/000508237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383201/
https://www.ncbi.nlm.nih.gov/pubmed/32774296
http://dx.doi.org/10.1159/000508237

Ejemplares similares